Transforming Retinal Disease Management with Novel Therapies

home / peer-exchange / transforming-retinal-disease-management-with-novel-therapies

A panel of ophthalmologists and vitreoretinal specialists discuss treatments for retinal diseases, specifically neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME). Experts highlight two new therapies, aflibercept 8 mg and faricimab, and how the addition of biosimilars and gene therapy are changing the landscape of care for the better.

© 2024 MJH Life Sciences

All rights reserved.